TWST · Twist Bioscience Corporation

Summary

Twist Bioscience Corporation entered into Stock Purchase Agreements on February 11, 2026, to issue up to 632,328 shares of common stock: up to 324,558 shares to Invenra Inc. with $5 million cash for a license and technology transfer, and 307,770 shares to two Invenra investors for approximately 6% ownership in Invenra. The company also gained the right to designate one director to the Invenra board and entered Registration Rights Agreements for share resale registration.

Key takeaways

• Stock Purchase Agreements dated February 11, 2026 with certain investors
• Issuance of up to 632,328 shares of common stock, par value $0.00001
• 324,558 shares and $5 million cash to Invenra for license agreement and technology transfer
• 307,770 shares to two Invenra investors for ~6% ownership in Invenra
• Right to designate one director to Invenra board
• Registration Rights Agreements filed as Exhibit 4.1; opinion as Exhibit 5.1